NASDAQ:IBB

iShares Biotechnology ETF - IBB Stock Forecast, Price & News

$131.29

-1.75 (-1.32%)

(As of 08/11/2022 12:00 AM ET)

Add

Compare

Today's Range: $130.81
▼
$135.08
50-Day Range: $105.82
▼
$133.04
52-Week Range: $104.29
▼
$176.02

Volume: 2.12 million shs
Average Volume: 2.60 million shs
Market Capitalization: $8.52 billion

P/E Ratio: N/A
Dividend Yield: 0.24%
Price Target: N/A

Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

30 days | 90 days | 365 days | Advanced Chart

Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer BlackRock

Fund NameiShares Nasdaq Biotechnology ETF

Tax ClassificationRegulated Investment Company

SymbolNASDAQ:IBB

Inception Date2/5/2001

Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason

WebN/A

PhoneN/A

Fund Focus

Asset ClassEquity

BenchmarkNASDAQ Biotechnology Index

CategorySector

FocusHealth Care

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$7.70 billion

Average Daily Volume$2.62 million

Discount/Premium0.08%

ETF Expenses

Management Fee0.47%

Other Expenses0.00%

Total Expenses0.47%

Fee Waiver0.00%

Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company

AdvisorBlackRock Fund Advisors

CustodianState Street Bank and Trust Company

DistributorBlackRock Investments, LLC

Transfer AgentState Street Bank and Trust Company

Trustee

Lead Market MakerVirtu Financial

Geographic Exposure of IBB

Currency Exposure of IBB

Sector Exposure of IBB

Industry Exposure of IBB

Key Executives

George G. C. Parker Ph.D.
Independent Chairman of the Board of Trustees
Michael Arthur Latham
President, Trustee
Jack Gee
Chief Financial Officer, Treasurer
Geoffrey D. Flynn
Chief Operating Officer, Executive Vice President
Bio & Compensation -
Amy Schioldager
Executive Vice President
Ira P. Shapiro
Vice President, Chief Legal Officer
Matt Tucker
Vice President
Bio & Compensation -
Eilleen M. Clavere
Secretary
Cecilia H. Herbert
Independent Trustee
Charles A. Hurty
Independent Trustee

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

IBB Stock - Frequently Asked Questions

How have IBB shares performed in 2022?: iShares Biotechnology ETF's stock was trading at $152.62 at the beginning of the year. Since then, IBB stock has decreased by 13.8% and is now trading at $131.60.
View the best growth stocks for 2022 here.
How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?: iShares Biotechnology ETF declared a quarterly dividend on Wednesday, June 8th. Shareholders of record on Friday, June 10th will be given a dividend of $0.031 per share on Wednesday, June 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.09%. The ex-dividend date is Thursday, June 9th.
Read our dividend analysis for IBB.
Is iShares Biotechnology ETF a good dividend stock?: iShares Biotechnology ETF (NASDAQ:IBB) pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.24%.
Read our dividend analysis for IBB.
When did iShares Biotechnology ETF's stock split?: iShares Biotechnology ETF shares split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What other stocks do shareholders of iShares Biotechnology ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).
What is iShares Biotechnology ETF's stock symbol?: iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."
Who are iShares Biotechnology ETF's major shareholders?: iShares Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (0.63%), Bronte Capital Management Pty Ltd. (0.44%), Bank Julius Baer & Co. Ltd Zurich (0.29%), Commonwealth Equity Services LLC (0.29%), Baird Financial Group Inc. (0.28%) and Advisor Group Holdings Inc. (0.27%).
How do I buy shares of iShares Biotechnology ETF?: Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iShares Biotechnology ETF's stock price today?: One share of IBB stock can currently be purchased for approximately $131.60.
How much money does iShares Biotechnology ETF make?: iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $8.57 billion.

This page (NASDAQ:IBB) was last updated on 8/11/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources